 A series of novel berberine analogues were prepared and tested for their antiviral potencies against six different genotype Coxsackievirus B strains taking BBR core for structural modification . Structure activity relationship research revealed that introduction of a primary amine through a linker at position 3 might be beneficial for both antiviral activity and safety . Compound

@highlight BBR derivatives were considered to be a new family of broad spectrum anti CVBs agents.
@highlight Compound
@highlight displayed most promising inhibitory potency against tested CVBs strains.
@highlight Compound
@highlight inhibits CVB3 replication through down regulating the expression of VP1 protein and VP1 RNA.
@highlight Compound
@highlight could suppress host components JNK MAPK ERK MAPK and p38 MAPK activation.
